American Strategic Investment (NYC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 Apr, 2026Executive summary
Portfolio consists of five Manhattan-focused mixed-use office and retail assets with 80.3% occupancy and a weighted average lease term of 6.1 years.
69% of top 10 tenants are investment grade or implied investment grade, with a balanced mix across government, non-profit, retail, fitness, and professional services sectors.
Active management included 13 new and replacement leases totaling 117,000 sq ft in 2025 and property dispositions, including a consensual foreclosure, to reduce expenses and debt.
Completed the disposition of 1140 Avenue of the Americas, recognizing a $46.6 million gain and eliminating $99 million in upcoming debt maturity.
Terminated REIT status effective January 1, 2023, with business operations remaining largely unchanged.
Financial highlights
Full-year 2025 revenue was $43.3 million, down from $61.6 million in 2024, mainly due to property dispositions; Q4 2025 revenue was $6.5 million.
Full-year GAAP net loss attributable to common stockholders was $21.2 million, improved from a $140.6 million loss in 2024; Q4 net loss was $6.7 million.
Adjusted EBITDA for 2025 was $0.3 million; Q4 Adjusted EBITDA was $1.2 million.
Cash NOI for 2025 was $16 million; Q4 Cash NOI was $1.8 million.
Real estate assets at cost totaled $382.5 million as of December 31, 2025.
Outlook and guidance
Exploring sales of 123 William Street and 196 Orchard Street to generate cash for higher-yielding investments and diversify outside Manhattan.
Focus remains on leasing up available space, renewing leases, maintaining expense controls, and stable occupancy.
No debt maturities until 2027, supporting near-term financial stability.
Latest events from American Strategic Investment
- Director elections, auditor change, and say-on-pay headline a governance-focused annual meeting.NYC
Proxy filing23 Apr 2026 - Virtual 2026 meeting to vote on directors, auditor, and executive pay, with online participation.NYC
Proxy filing23 Apr 2026 - $91.9M net loss on $84.7M impairment, $63.5M sale pending, EBITDA and occupancy up.NYC
Q2 20241 Feb 2026 - Q3 net loss rose on impairments; 9 Times Square sale to cut leverage and boost diversification.NYC
Q3 202414 Jan 2026 - Net loss narrowed in Q4 2024 as asset sales improved leverage and a new CEO was appointed.NYC
Q4 202424 Dec 2025 - Annual meeting to vote on director, auditor, and say-on-pay, with all proposals recommended for approval.NYC
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on director, auditor, and executive pay on May 29, 2025.NYC
Proxy Filing1 Dec 2025 - Revenue and NOI fell, losses widened, but occupancy rose and liquidity risks remain.NYC
Q1 202526 Nov 2025 - Revenue fell, losses narrowed, and liquidity risks rose as asset sales and foreclosures continued.NYC
Q2 202523 Nov 2025